CBLL News
Archived Headlines
- US IPO Week Ahead: Quiet week expected after flurry of biotech IPOs 09/13/24
- US IPO Week Ahead: A trio of biotechs kick off fall IPO market 09/06/24
- Renaissance Capital's August IPO Market Update 09/03/24
- US IPO Weekly Recap: Small issuers close out August IPO market 08/30/24
- Seizure diagnostic company Ceribell files for a $100 million IPO 08/26/24
US IPO Weekly Recap: Active IPO market continues with KinderCare and trio of biotech deals
Four IPOs each raised at least $75 million this week as the Fall IPO market continued to hum along, while one company postponed its deal. Early childhood education (ECE) provider KinderCare (KLC) priced just below the midpoint of the range...read more
Seizure diagnostic company CeriBell prices IPO at $17, the high end of the upwardly revised range
CeriBell, which makes a point-of-care rapid EEG to detect and monitor seizures in acute care, raised $180 million by offering 10.6 million shares at $17, the high end of the range of $16 to $17. The company had originally filed to offer 6.7 million shares at a...read more
Seizure diagnostic company CeriBell ups shares by 58%, increases range ahead of $175 million IPO
CeriBell, a medical device maker with an EEG platform that uses AI to monitor patient seizures, raised the proposed deal size for its upcoming IPO on Wednesday. The Sunnyvale, CA-based company now plans to raise $175 million by offering 10.6 million shares at a...read more
Seizure diagnostic company CeriBell sets terms for $101 million IPO
CeriBell, a medical device maker with an EEG platform that uses AI to monitor patient seizures, announced terms for its IPO on Monday. The Sunnyvale, CA-based company plans to raise $101 million by offering 6.7 million shares at a price range of $14 to $16. At...read more